These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 61475)

  • 41. Clinical studies with Corynebacterium parvum.
    Mitcheson HD; Castro JE
    Dev Biol Stand; 1977 Apr 13-15; 38():509-14. PubMed ID: 344105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intrapleural immunotherapy with Corynebacterium parvum in recurrent malignant pleural effusions.
    Millar JW; Hunter AM; Horne NW
    Thorax; 1980 Nov; 35(11):856-8. PubMed ID: 7221983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of an intracerebral rat brain tumor with Corynebacterium parvum and radiation.
    Douple EB
    Natl Cancer Inst Monogr; 1977 Dec; 46():179-84. PubMed ID: 206836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Histopathological aspects and macrophage reactivity in rats with Guerin's T8 viral tumor after treatment with Corynebacterium parvum].
    Caruso R; Bonina L; Chimicata S; Iannello D; Inferrera C; Mastroeni P
    Arch De Vecchi Anat Patol; 1979 Mar; 63(3):491-9. PubMed ID: 262125
    [No Abstract]   [Full Text] [Related]  

  • 45. Biotyping and serotyping of Propionibacterium acnes strains isolated from different diagnostic materials.
    Sourek J; Hudác A
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(4):494-9. PubMed ID: 983535
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Preliminary considerations on the intravenous use of Corynebacterium parvum in the treatment of solid neoplasms].
    Scheinberg MA; Sartori JP; de Pinho JG
    AMB Rev Assoc Med Bras; 1979 Apr; 25(4):139-40. PubMed ID: 315598
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunomodulation of chemically induced fibrosarcoma by Corynebacterium parvum.
    Gupta N; Sehgal S; Aikat BK
    Indian J Med Res; 1980 Nov; 72():688-95. PubMed ID: 7203570
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
    Kreider JW; Bartlett GL; Purnell DM; Webb S
    Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Corynebacterium parvum and chronic Toxoplasma infection on metastatic brain tumors in mice.
    Conley FK
    J Natl Cancer Inst; 1979 Nov; 63(5):1237-44. PubMed ID: 291750
    [No Abstract]   [Full Text] [Related]  

  • 50. Intrapleural Corynebacterium parvum for malignant pleural effusions.
    Felletti R; Ravazzoni C
    Thorax; 1983 Jan; 38(1):22-4. PubMed ID: 6845257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lack of effect of immunotherapy with BCG and Corynebacterium parvum on hepatic drug hydroxylation in man.
    Wan HH; Thatcher N; Mullen PW; Smith GN; Wilkinson PM
    Br J Cancer; 1979 Apr; 39(4):441-4. PubMed ID: 444399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proliferative glomerulonephritis and chronic active hepatitis with cirrhosis associated with Corynebacterium parvum immunotherapy in a dog.
    Leifer CE; Page RL; Matus RE; Patnaik AK; MacEwen EG
    J Am Vet Med Assoc; 1987 Jan; 190(1):78-80. PubMed ID: 3818425
    [No Abstract]   [Full Text] [Related]  

  • 53. Combined use of local irradiation and Corynebacterium parvum in the treatment of the murine line 1 lung carcinoma.
    Ullrich RL; Adams LM
    Radiat Res; 1978 Feb; 73(2):267-73. PubMed ID: 204955
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of Corynebacterium parvum on tumor growth in the central nervous system of mice.
    Conley FK; Remington JS
    J Natl Cancer Inst; 1978 Sep; 61(3):827-32. PubMed ID: 278860
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunotherapy of cancer with corynebacterium parvum.
    Halpern B
    Ann Allergy; 1978 Mar; 40(3):155-7. PubMed ID: 637374
    [No Abstract]   [Full Text] [Related]  

  • 56. [Prospects of short-term sequential immunomodulation with levamisole and Corynebacterium parvum in neoplastic pathology in the aged].
    Palmieri B; Marsiai M; Gasparini Casari M; Noera G
    Minerva Med; 1979 May; 70(25):1787-93. PubMed ID: 460632
    [No Abstract]   [Full Text] [Related]  

  • 57. [Antitumoral activity of various doses of corynebacterium parvum as a function of the age of mice].
    Stiffel C; Chalvet H; Mazurek C
    Ann Inst Pasteur Immunol (1985); 1985; 136D(1):19-27. PubMed ID: 3840664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antitumor activity of Corynebacterium parvum extracts.
    McBride WH; Dawes J; Tuach S
    J Natl Cancer Inst; 1976 Feb; 56(2):437-9. PubMed ID: 1255777
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Active experimental inhibition of cancer by corynebacterium parvum.
    Wrba H; Dutter A
    Osterr Z Onkol; 1977 Oct; 4(2-3):60-1. PubMed ID: 579449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Immunotherapy of breast cancer (review of foreign literature)].
    Liapis MA
    Vopr Onkol; 1983; 29(8):68-74. PubMed ID: 6351428
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.